1. Home
  2. CHRS vs ALOT Comparison

CHRS vs ALOT Comparison

Compare CHRS & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRS
  • ALOT
  • Stock Information
  • Founded
  • CHRS 2010
  • ALOT 1969
  • Country
  • CHRS United States
  • ALOT United States
  • Employees
  • CHRS N/A
  • ALOT N/A
  • Industry
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • ALOT Computer peripheral equipment
  • Sector
  • CHRS Health Care
  • ALOT Technology
  • Exchange
  • CHRS Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • CHRS 94.0M
  • ALOT 81.6M
  • IPO Year
  • CHRS 2014
  • ALOT N/A
  • Fundamental
  • Price
  • CHRS $0.91
  • ALOT $8.94
  • Analyst Decision
  • CHRS Strong Buy
  • ALOT
  • Analyst Count
  • CHRS 4
  • ALOT 0
  • Target Price
  • CHRS $5.38
  • ALOT N/A
  • AVG Volume (30 Days)
  • CHRS 2.1M
  • ALOT 12.7K
  • Earning Date
  • CHRS 05-08-2025
  • ALOT 04-14-2025
  • Dividend Yield
  • CHRS N/A
  • ALOT N/A
  • EPS Growth
  • CHRS N/A
  • ALOT 12.82
  • EPS
  • CHRS 0.25
  • ALOT 0.51
  • Revenue
  • CHRS $266,959,999.00
  • ALOT $153,515,000.00
  • Revenue This Year
  • CHRS N/A
  • ALOT N/A
  • Revenue Next Year
  • CHRS $9.02
  • ALOT N/A
  • P/E Ratio
  • CHRS $3.66
  • ALOT $17.61
  • Revenue Growth
  • CHRS 3.78
  • ALOT 3.48
  • 52 Week Low
  • CHRS $0.66
  • ALOT $8.33
  • 52 Week High
  • CHRS $2.61
  • ALOT $18.25
  • Technical
  • Relative Strength Index (RSI)
  • CHRS 45.16
  • ALOT 35.41
  • Support Level
  • CHRS $0.89
  • ALOT $8.58
  • Resistance Level
  • CHRS $1.07
  • ALOT $9.28
  • Average True Range (ATR)
  • CHRS 0.09
  • ALOT 0.54
  • MACD
  • CHRS -0.00
  • ALOT -0.07
  • Stochastic Oscillator
  • CHRS 44.79
  • ALOT 20.96

About CHRS Coherus BioSciences Inc.

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: